The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Regular aspirin (ASA) use and survival in patients with PIK3CA-mutated metastatic colorectal cancer (CRC).
Nishi Kothari
No relevant relationships to disclose
Richard D. Kim
No relevant relationships to disclose
Peter Gibbs
No relevant relationships to disclose
Timothy Joseph Yeatman
No relevant relationships to disclose
Michael J. Schell
No relevant relationships to disclose
Jayesh Desai
No relevant relationships to disclose
Jeanne Tie
No relevant relationships to disclose
Lara Rachel Lipton
No relevant relationships to disclose
Robert N. Jorissen
No relevant relationships to disclose
Hui-Li Wong
No relevant relationships to disclose
Oliver Sieber
No relevant relationships to disclose
Fiona Day
No relevant relationships to disclose
Ian Faragher
No relevant relationships to disclose
Ian Jones
No relevant relationships to disclose
Ben Tran
No relevant relationships to disclose